Roivant Sciences reposted this
When Ethan Hsu was in high school his father developed diabetic retinopathy, a chronic eye condition that occurs when diabetes damages the retina's blood vessels. Through a clinical trial, Ethan's dad was able to receive treatments that drastically improved his vision. Ethan saw first-hand the dramatic impact that drug development can have on quality of life for sick patients, which inspired him to begin pursuing a career in medicine through pharmacology competitions while he was still in high school. Ethan was the first person in his family to graduate from college and received a Bachelor of Science in Cellular and Molecular Biology from the The University of Texas at Austin. As an undergraduate he conducted research in the Welsh Lab at MD Anderson Cancer Center. To date, he has published eight papers focused on treatment advancements in Immunology and Oncology. This summer Ethan is serving as a Research and Development (R&D) Intern for Roivant Sciences' Chemistry, Manufacturing, and Control (CMC) team. This internship is offering him the opportunity to further his research experience while directly learning about drug development. "I've always wanted to have hands-on experience in the pharmaceutical industry and I think that the work of the R&D department in Roivant's CMC is captivating, because the nature of the work is so new. The work is constantly growing and changing. For instance, even within the first week of my internship I was already getting to dive in on researching new technologies that not many people have gotten to touch. It's a great place to grow." Read more about Ethan's internship and Roivant Social Ventures' 2024 Access to Medicines Internship Program here: https://lnkd.in/gCRBGeDn UNC Eshelman School of Pharmacy #researchanddevelopment #research #healthcare #access #impact #medical #pharma #therapeutics #therapeutic #innovation #medicine #medicines #clinicaltrials #clinicaltrial #accessibility #healthcarenews #healthcareinnovation #raredisease #immunology #oncology #diabeticretinopathy #retinopathy